Back

Post-Receptor Dissociation of Estrogen Signaling in Macrophage-Infiltrated Meningiomas: A Multi-Method Deconvolution Study of 968 Transcriptomes

Piccolo, D.; Vindigni, M.

2026-05-21 oncology
10.64898/2026.05.19.26353588 medRxiv
Show abstract

Background. Meningiomas exhibit well-established hormonal biology, yet no study has examined whether myeloid immune infiltration interacts with estrogen-responsive transcription in this tumor type. Methods. We applied three-method consensus immune deconvolution (EPIC, MCPcounter, CIBERSORTx) to 968 harmonized meningioma RNA-seq transcriptomes from five public datasets, stratified by Thirimanne et al. (2024) transcriptomic subtypes. Competitive gene set enrichment compared macrophage-high versus macrophage-low tertiles with sex-adjusted, purity-adjusted, and method-independent sensitivity analyses. Survival modeling tested both total macrophage burden and a decomposed microglia-to-macrophage ratio validated against single-cell ground truth (pseudo-bulk r = 0.77). Results. Macrophage-high tumors showed significant suppression of estrogen response gene sets (FDR = 4.9 x 10-5) despite paradoxical ESR1 upregulation (log2FC = +0.40, FDR = 2.5 x 10-26) and PGR downregulation (log2FC = -0.34, FDR = 2.7 x 10-3), indicating post-receptor transcriptional disruption. This signal strengthened after sex adjustment (FDR = 1.9 x 10-6) and was confirmed across a multi-layer sensitivity battery (eleven analyses including reference-matrix-independent, purity-adjusted, rotation-based self-contained, and empirical-null tests; all FDR < 3 x 10-4 in the relevant convergent tests). Myeloid infiltration was strongly subtype-dependent (Kruskal-Wallis p = 7.4 x 10-16) but grade-independent (p = 0.399), with CSF1R enriched in the macrophage-dominant Cluster B. Neither total macrophage score (HR = 0.90, p = 0.53; N = 102) nor a decomposed microglia/macrophage ratio (HR = 0.92, p = 0.46; N = 101) predicted recurrence-free survival. Conclusions. The pre-registered primary endpoint - macrophage infiltration score predicting recurrence-free survival - was not supported; the estrogen-immune dissociation emerged from secondary exploratory gene-set analysis and requires independent validation. Macrophage-infiltrated meningiomas exhibit a previously unreported dissociation between maintained ESR1 expression and suppressed estrogen-responsive transcription, with implications for hormonal therapy stratification.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Clinical Cancer Research
58 papers in training set
Top 0.1%
14.1%
2
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.1%
9.9%
3
Nature Communications
4913 papers in training set
Top 26%
7.0%
4
Neuro-Oncology
30 papers in training set
Top 0.2%
6.7%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 15%
4.7%
6
Cancers
200 papers in training set
Top 1%
4.1%
7
Neuro-Oncology Advances
24 papers in training set
Top 0.2%
3.6%
50% of probability mass above
8
Breast Cancer Research
32 papers in training set
Top 0.2%
3.5%
9
Cancer Cell
38 papers in training set
Top 0.6%
3.0%
10
Cancer Research
116 papers in training set
Top 1%
3.0%
11
eLife
5422 papers in training set
Top 30%
3.0%
12
Scientific Reports
3102 papers in training set
Top 48%
2.3%
13
Clinical Epigenetics
53 papers in training set
Top 0.6%
1.7%
14
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.4%
1.7%
15
International Journal of Cancer
42 papers in training set
Top 0.7%
1.5%
16
Acta Neuropathologica
51 papers in training set
Top 0.8%
1.3%
17
Cell Genomics
162 papers in training set
Top 5%
1.2%
18
Brain, Behavior, & Immunity - Health
27 papers in training set
Top 0.3%
1.2%
19
Journal of Clinical Investigation
164 papers in training set
Top 5%
1.2%
20
European Journal of Cancer
10 papers in training set
Top 0.4%
0.9%
21
Annals of Oncology
13 papers in training set
Top 0.9%
0.8%
22
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 1%
0.8%
23
JNCI Cancer Spectrum
10 papers in training set
Top 0.5%
0.8%
24
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
25
iScience
1063 papers in training set
Top 30%
0.8%
26
Brain
154 papers in training set
Top 5%
0.7%
27
Cell Reports
1338 papers in training set
Top 34%
0.7%
28
Frontiers in Oncology
95 papers in training set
Top 4%
0.7%
29
The American Journal of Human Genetics
206 papers in training set
Top 4%
0.7%
30
Genome Medicine
154 papers in training set
Top 9%
0.7%